Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL617937 | 0.81 | MAPT (0.53) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL4447296 | 0.78 | HDAC3 (0.63) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28627442 | 0.78 | MAPT (0.57) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6904745 | 0.76 | CES1 (0.58) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28615437 | 0.75 | KCNN4 (0.62) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2028143 | 0.71 | KCNN4 (0.43) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1818707 | 0.71 | PPARA (0.47) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL20837204 | 0.69 | KCNN4 (0.48) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL10710208 | 0.69 | ALDH1A1 (0.46) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18259095 | 0.68 | CES1 (0.52) | KCNN4MAPTKMT2ACES1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198244-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2021-07-01 | — | — | US | disclosed |
| US-10745390-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-08-18 | — | — | US | disclosed |
| US-20170334890-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-11-23 | — | — | US | disclosed |
| US-9695157-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-07-04 | — | — | US | disclosed |
| US-20150210674-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-07-30 | — | — | US | disclosed |
| US-9000009-B2 | Small molecule activators of mitochondrial function | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-04-07 | — | — | US | disclosed |
| US-20120041023-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| WO-2010068767-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210674-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KCNN4 2964/4885HDAC3 2192/4885HDAC4 1157/4885 |
| US-20170334890-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KCNN4 2964/4885HDAC3 2192/4885HDAC4 1157/4885 |
| US-20120041023-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KCNN4 2739/4885HDAC3 1945/4885HDAC4 1092/4885 |
| US-10745390-B2 | Small molecule activators of mitochondrial function | TFAM, TFB2M, GFM1 | KCNN4 2964/4885HDAC3 2192/4885HDAC4 1157/4885 |
| US-20210198244-A1 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | TFAM, TFB2M, GFM1 | KCNN4 2964/4885HDAC3 2192/4885HDAC4 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.